PATENT CLAIM ANALYSIS

Application Number: 15892078
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "561000"]

Abstract:
Compositions contain citrulline and leucine or a metabolite thereof including, for example, a synergistic amount of citrulline and leucine. Such compositions may be used in methods for the treatment of pre-diabetes, metabolic syndrome, hyperglycemia, or diabetes.

Claim (Index 12):
The method of  claim 1 , wherein the method is effective to achieve at least one modification selected from the group consisting of: reduction in fasting blood sugar level, decrease in insulin resistance, reduction of hyperinsulinemia, improvement in glucose tolerance, reduction in systemic inflammation, reduction in the need for diabetes medication, decrease in serum lipids with improvement in the lipid profile, and decrease in one or more cardiovascular risk indicators.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15027580', '15891324', '14248787', '14851668', '15226267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7587632538243964
- 35 USC 102 Novelty (BERT): 0.5463733915717012
- Combined Prediction Score: 0.7375242675991269
- Mean Citation Score: 259.033282
- Max Citation Score: 406.64493
- Similarity Product: 311.25528524628817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test